Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $95 Million
  • Q2 2025

Birchview Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $95 Million distributed in 71 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $15M, Kla Corp with a value of $14.2M, Corcept Therapeutics Inc with a value of $4.93M, Ovintiv Inc. with a value of $4.09M, and Acadia Pharmaceuticals Inc with a value of $4.05M.

Examining the 13F form we can see an decrease of $16M in the current position value, from $111M to 95M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $95 Million
Healthcare: $73.9 Million
Technology: $14.2 Million
Energy: $6.11 Million
Basic Materials: $781,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$99.3B
$15 Million 15.76% of portfolio
323,358
Q2 2025 Reduced 52.81%
$129B
$14.2 Million 14.95% of portfolio
15,848
Q2 2025 New
$7.63B
$4.93 Million 5.19% of portfolio
67,200
Q2 2025 Added 1.82%
$10.4B
$4.09 Million 4.31% of portfolio
107,500
Q2 2025 Added 105.94%
$4.11B
$4.05 Million 4.27% of portfolio
187,800
Q2 2025 Reduced 28.7%
$13.8B
$3.89 Million 4.09% of portfolio
30,940
Q2 2025 Added 2.31%
$1.41B
$3.26 Million 3.44% of portfolio
114,700
Q4 2023 Added 38.69%
$398M
$2.74 Million 2.88% of portfolio
451,019
Q2 2025 Added 35.45%
$2.76B
$2.65 Million 2.79% of portfolio
48,000
Q2 2025 Reduced -0.0%
$867M
$2.38 Million 2.51% of portfolio
210,000
Q2 2025 Reduced -0.0%
$633M
$2.26 Million 2.38% of portfolio
110,600
Q2 2025 Added 25.11%
$18.6B
$2.02 Million 2.13% of portfolio
34,619
Q3 2024 New
$1.08B
$1.83 Million 1.93% of portfolio
60,000
Q2 2025 Reduced 17.71%
$1.32B
$1.8 Million 1.89% of portfolio
101,000
Q2 2025 Added 225.81%
$678M
$1.75 Million 1.84% of portfolio
161,000
Q2 2024 Added 13.87%
$13.5M
$1.68 Million 1.77% of portfolio
1,159,059
Q2 2025 Reduced 2.41%
$1.36B
$1.52 Million 1.6% of portfolio
103,000
Q2 2025 Reduced 25.36%
$239M
$1.46 Million 1.54% of portfolio
310,930
Q4 2024 Reduced 3.12%
$4.67B
$1.43 Million 1.51% of portfolio
50,000
Q2 2021 Added 42.86%
$7.82B
$1.39 Million 1.47% of portfolio
8,280
Q2 2025 Reduced 26.6%
$814M
$1.38 Million 1.45% of portfolio
98,697
Q2 2025 Added 11.27%
$18B
$1.22 Million 1.29% of portfolio
4,250
Q2 2025 Reduced 43.33%
$159M
$1.2 Million 1.26% of portfolio
764,062
Q2 2025 Reduced 11.57%
$394M
$1.04 Million 1.1% of portfolio
176,947
Q2 2025 Added 7.28%
$1.26B
$830,000 0.87% of portfolio
30,000
Q2 2025 Reduced 0.02%
$66.7B
$781,000 0.82% of portfolio
18,033
Q2 2025 New
$393M
$757,000 0.8% of portfolio
67,000
Q2 2025 Reduced -0.0%
$663M
$664,000 0.7% of portfolio
34,584
Q2 2025 Added 40.68%
$2.21B
$654,000 0.69% of portfolio
18,000
Q2 2025 Added 12.5%
$2.38B
$657,000 0.69% of portfolio
21,000
Q3 2023 Reduced 52.38%
$5.54B
$626,000 0.66% of portfolio
6,000
Q1 2024 Reduced 33.33%
$301M
$570,000 0.6% of portfolio
134,000
Q2 2025 New
$1.63B
$566,000 0.6% of portfolio
16,000
Q4 2024 Reduced 50.0%
$108M
$558,000 0.59% of portfolio
60,000
Q2 2025 New
$479M
$558,000 0.59% of portfolio
26,000
Q2 2025 Added 30.0%
$900M
$562,000 0.59% of portfolio
60,000
Q2 2025 New
$502M
$550,000 0.58% of portfolio
70,000
Q2 2025 Added 169.23%
$10.6B
$520,000 0.55% of portfolio
10,000
Q4 2022 New
$281M
$496,000 0.52% of portfolio
400,000
Q2 2025 New
$2.19B
$377,000 0.4% of portfolio
8,000
Q4 2024 Reduced 50.0%
$1.71B
$366,000 0.39% of portfolio
33,000
Q4 2024 Reduced 70.71%
$1.52B
$358,000 0.38% of portfolio
40,000
Q2 2024 Added 100.0%
$7.73B
$346,000 0.36% of portfolio
2,700
Q3 2024 New
$4.9B
$330,000 0.35% of portfolio
10,000
Q1 2024 Reduced 60.0%
$146M
$303,000 0.32% of portfolio
60,000
Q4 2024 New
$32.2M
$300,000 0.32% of portfolio
155,000
Q4 2024 Reduced 19.35%
$834M
$287,000 0.3% of portfolio
40,000
Q2 2025 New
$658M
$261,000 0.27% of portfolio
40,300
Q4 2023 Reduced 0.74%
$1.32B
$254,000 0.27% of portfolio
22,000
Q2 2025 Reduced 56.0%

Summary

  • Portfolio
  • No. of Stocks 71
  • Current Value $95 Million
  • Prior Value $111 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email